Document is current
Any future updates will be listed below
-
Authors
Lier, Heiko https://orcid.org/0000-0001-7374-4324
Goossen, Käthe https://orcid.org/0000-0002-1436-1144
Kugler, Charlotte M. https://orcid.org/0000-0003-4170-3290
Strasser, Erwin https://orcid.org/0000-0002-8113-0522
Hussmann, Björn https://orcid.org/0000-0001-8333-6367
Maegele, Marc https://orcid.org/0000-0002-0634-4723
Hilbert-Carius, Peter https://orcid.org/0000-0002-4704-2377
-
Funding
Funding for this research was provided by:
Private Universität Witten/Herdecke gGmbH
- License Information
-
More Information
Article History
Received: 31 March 2025
Accepted: 10 June 2025
First Online: 27 June 2025
Declarations
:
: Ethical approval was not required, because the study used publicly accessible documents as evidence.
: Heiko Lier declares that he has received honoraria for lectures and travel fees from AstraZeneca, Bayer Vital, DRK-Blutspendedienst West, CSL Behring, Ferring, Mitsubishi Pharma, NovoNordisk, Organon, and Werfen. Marc Maegele declares that he has received honoraria for lectures, participation in expert/advisory board committees and financial support for participation in congresses and scientific projects from Abbott, Astra Zeneca, Baxter, Bayer, Biotest, CSL Behring, IL-Werfen/TEM-International, LFB, Biomedicaments France, Portola, and Octapharma. Käthe Goossen, Charlotte M. Kugler, Erwin Strasser, Bjoern Hussmann, and Peter Hilbert‐Carius declare no competing interests.
